Prurigo nodularis responding to intravenous immunoglobulins

Koray Durmaz; Arzu Ataseven; Ilkay Ozer; Sıddıka Fındık

doi:10.5114/dr.2022.117988

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

2/2022
vol. 109

Send email

Copy url:

abstract:

Letter to the Editor

Prurigo nodularis responding to intravenous immunoglobulins

Koray Durmaz

¹

,

Arzu Ataseven

²

,

Ilkay Ozer

²

,

Sıddıka Fındık

³

Yasam Hospital Clinic of Dermatology, Kirikkale, Turkey

Department of Dermatology, Faculty of Medicine, Necmettin Erbakan University Meram, Konya, Turkey

Department of Pathology, Faculty of Medicine, Necmettin Erbakan University Meram, Konya, Turkey

Dermatol Rev/Przegl Dermatol 2022, 109, 159-162

DOI: https://doi.org/10.5114/dr.2022.117988

Online publish date: 2022/07/08

View full text Get citation

PlumX metrics:

Prurigo nodularis is a chronic skin disease, especially seen in middle-aged women adults. It is characterized by symmetric, pruritic hyperkeratotic nodules and papules on the extensor surfaces [1]. Prurigo nodularis patients can suffer from repeated itching and scratching cycles or intensive pruritus. The etiology of prurigo nodularis is not clear. The lesions can be seen primarily or be caused by another pruritic condition. The trigger can be other dermatoses such as atopic dermatitis or secondary pruritus due to another systemic disease such as chronic kidney disease, jaundice, malignancies, etc. The interaction between cutaneous nerve fibers and immune cells can play a crucial role in pathogenesis [2]. Treatment options for prurigo nodularis are limited by studies. Most of the studies aim at symptomatic relief of patients [3].

Prurigo nodularis responding to intravenous immunoglobulins

Koray Durmaz 1 , Arzu Ataseven 2 , Ilkay Ozer 2 , Sıddıka Fındık 3

Koray Durmaz

¹

,

Arzu Ataseven

²

,

Ilkay Ozer

²

,

Sıddıka Fındık

³